A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid

Clinical trial NCT05681481 · TERMINATED

Trial details

NCT number: NCT05681481
Sponsor: argenx
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bullous Pemphigoid

Start date: 2023-03-22
Primary completion: 2025-03-20
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.